Skip to content
Search

Latest Stories

NPA roundtable recommends action plan for pharmacists to help people with obesity

A roundtable organized by National Pharmacists Association (NPA) discussed how an enhanced role of community pharmacies could help people with obesity.

Seven action points were recommended by the delegates at the virtual event which took place on March 31, in collaboration with Novo Nordisk.


It was chaired by Professor Maggie Rae, president of the Faculty of Public Health and featured representatives from the Royal Pharmaceutical Society, Royal Society for Public Health, Patients Association, UK Health Security Agency, Diabetes UK and NHS England.

The roundtable also heard testimony from a parent of a young adult living with obesity and a presentation of the personal experience of someone living with the condition by Sarah Le Brocq, director of campaign group, All About Obesity.

The delegates came up with seven recommendations on how the role of community pharmacies can be enhanced and enabled further to help those living with obesity. They are:

  1. All people living with type 1 and type 2 diabetes should have access to weight management services with a specific focus on community pharmacy provision.
  2. Weight management and obesity services should have a greater focus on children and young adults, so that we can have the right conversations regarding healthy weight and intervene at an early point.
  3. All of us within the health and social care system should talk about people that are living with obesity. We should use this terminology to help stop the blame and stigma. It is as much an illness as any other illness.
  4. Promote community pharmacy as the setting for person centred services that can help people living with obesity. Continue to build on the strengths of community pharmacy which is a part of the NHS service offering.
  5. Use Health Champions, Social Prescribing services, and localized health services to enhance the community pharmacy service across the United Kingdom.
  6. Improving pharmacy teams’ knowledge, skills, understanding and practical application of obesity and obesity services, including the pharmacy undergraduate curriculum.
  7. Seek opportunities that are likely to emerge from the genetic and digital revolutions to improve services to those living with obesity.

Helga Mangion, policy manager at the NPA, said: “I thank those living with obesity on sharing their experiences. It was great to see so many healthcare professionals bringing together their expertise in one place and I’m delighted that the NPA was able to facilitate such an important conversation.

“With obesity levels on the increase across the UK and the ability for patients to easily access community pharmacy, community pharmacy has an important role to play in the prevention and management of the condition."

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less